Skip to content
10-Q

Quarterly Report

Lineage Cell Therapeutics, Inc. LCTX

0000950170-25-107333

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 6, 2025 228.36M sh
Shares Diluted Q2 2025 · Jun 30, 2025 228.36M sh
Shares Diluted Q2 2025 · Jun 30, 2025 227.21M sh
Shares Diluted Q2 2025 · Jun 30, 2024 188.81M sh
Shares Diluted Q2 2025 · Jun 30, 2024 185.86M sh
Capex Q2 2025 · Jun 30, 2025 $111K
Capex Q2 2025 · Jun 30, 2024 $88K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$10.43M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$10.96M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $42.27M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $45.79M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $29.62M
Stockholders Equity Q2 2025 · Jun 30, 2025 $48.39M
Stockholders Equity Q2 2025 · Dec 31, 2024 $78.38M
Current Liabilities Q2 2025 · Jun 30, 2025 $10.76M
Current Liabilities Q2 2025 · Dec 31, 2024 $13.98M
Total Liabilities Q2 2025 · Jun 30, 2025 $43.69M
Total Liabilities Q2 2025 · Dec 31, 2024 $36.21M
Current Assets Q2 2025 · Jun 30, 2025 $43.84M
Current Assets Q2 2025 · Dec 31, 2024 $51M
Total Assets Q2 2025 · Jun 30, 2025 $90.8M
Total Assets Q2 2025 · Dec 31, 2024 $113.22M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.13
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.15
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.03
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.07
Eps Basic Q2 2025 · Jun 30, 2025 −$0.13
Eps Basic Q2 2025 · Jun 30, 2025 −$0.15
Eps Basic Q2 2025 · Jun 30, 2024 −$0.03
Eps Basic Q2 2025 · Jun 30, 2024 −$0.07
Sga Expense Q2 2025 · Jun 30, 2025 $4.56M
Sga Expense Q2 2025 · Jun 30, 2025 $9.42M
Sga Expense Q2 2025 · Jun 30, 2024 $4.36M
Sga Expense Q2 2025 · Jun 30, 2024 $9.36M
Rd Expense Q2 2025 · Jun 30, 2025 $3.11M
Rd Expense Q2 2025 · Jun 30, 2025 $6.22M
Rd Expense Q2 2025 · Jun 30, 2024 $2.87M
Rd Expense Q2 2025 · Jun 30, 2024 $5.88M
Net Income Q2 2025 · Jun 30, 2025 −$30.46M
Net Income Q2 2025 · Jun 30, 2025 −$34.6M
Net Income Q2 2025 · Jun 30, 2024 −$5.76M
Net Income Q2 2025 · Jun 30, 2024 −$12.3M
Operating Income Q2 2025 · Jun 30, 2025 −$19.78M
Operating Income Q2 2025 · Jun 30, 2025 −$26.29M
Operating Income Q2 2025 · Jun 30, 2024 −$5.87M
Operating Income Q2 2025 · Jun 30, 2024 −$12.53M
Revenue Q2 2025 · Jun 30, 2025 $2.77M
Revenue Q2 2025 · Jun 30, 2025 $4.27M
Revenue Q2 2025 · Jun 30, 2024 $1.41M
Revenue Q2 2025 · Jun 30, 2024 $2.85M
Stock Issued Q2 2025 · Jan 27, 2025 39.47M sh